Kalpana Tilekar

675 total citations
24 papers, 577 citations indexed

About

Kalpana Tilekar is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Kalpana Tilekar has authored 24 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Kalpana Tilekar's work include Synthesis and biological activity (11 papers), Histone Deacetylase Inhibitors Research (9 papers) and Click Chemistry and Applications (6 papers). Kalpana Tilekar is often cited by papers focused on Synthesis and biological activity (11 papers), Histone Deacetylase Inhibitors Research (9 papers) and Click Chemistry and Applications (6 papers). Kalpana Tilekar collaborates with scholars based in India, United States and Germany. Kalpana Tilekar's co-authors include C. S. Ramaa, Neha Upadhyay, Franz‐Josef Meyer‐Almes, Vijay Patil, Jun‐yong Choe, Vadim S. Pokrovsky, Antonio Lavecchia, Piotr Mrówka, Cristina V. Iancu and Renato J. Aguilera and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Kalpana Tilekar

24 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kalpana Tilekar India 15 366 312 75 75 39 24 577
Hea-Young Park Choo South Korea 13 278 0.8× 278 0.9× 72 1.0× 121 1.6× 46 1.2× 20 632
Olga E. Andreeva Russia 14 119 0.3× 231 0.7× 66 0.9× 72 1.0× 37 0.9× 40 406
V. Vigneshwaran India 14 183 0.5× 203 0.7× 87 1.2× 71 0.9× 45 1.2× 27 447
Anna I. Koutsourea Greece 13 226 0.6× 198 0.6× 66 0.9× 30 0.4× 32 0.8× 22 377
Hongchan An South Korea 14 180 0.5× 228 0.7× 65 0.9× 27 0.4× 15 0.4× 35 482
Lan Shen United States 12 282 0.8× 241 0.8× 68 0.9× 46 0.6× 11 0.3× 23 532
Yasmin M. Attia Egypt 13 152 0.4× 224 0.7× 70 0.9× 89 1.2× 22 0.6× 20 445
Sudhakar Manda India 10 217 0.6× 260 0.8× 72 1.0× 48 0.6× 39 1.0× 12 496
Koji Ohsumi Japan 9 492 1.3× 286 0.9× 97 1.3× 63 0.8× 41 1.1× 10 652
Eman Y. Ahmed Egypt 12 254 0.7× 154 0.5× 67 0.9× 27 0.4× 29 0.7× 18 382

Countries citing papers authored by Kalpana Tilekar

Since Specialization
Citations

This map shows the geographic impact of Kalpana Tilekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalpana Tilekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalpana Tilekar more than expected).

Fields of papers citing papers by Kalpana Tilekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalpana Tilekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalpana Tilekar. The network helps show where Kalpana Tilekar may publish in the future.

Co-authorship network of co-authors of Kalpana Tilekar

This figure shows the co-authorship network connecting the top 25 collaborators of Kalpana Tilekar. A scholar is included among the top collaborators of Kalpana Tilekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalpana Tilekar. Kalpana Tilekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upadhyay, Neha, et al.. (2024). Design, in silico studies, synthesis, and in vitro anticancer assessment of new naphthylidene isoxazolidinedione derivatives. Vietnam Journal of Chemistry. 62(2). 217–226. 1 indexed citations
2.
Tilekar, Kalpana, et al.. (2022). Recent Discoveries of Nitrogen-Containing Heterocyclic Compounds asInhA Inhibitors against Mycobacterium tuberculosis: An Overview. Infectious Disorders - Drug Targets. 22(8). 19–29. 3 indexed citations
3.
Tilekar, Kalpana, Neha Upadhyay, Antonio Laghezza, et al.. (2021). Thiazolidinedione “Magic Bullets” Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their In Vitro and In Vivo Antitumor Effects. Journal of Medicinal Chemistry. 64(10). 6949–6971. 29 indexed citations
4.
Upadhyay, Neha, Kalpana Tilekar, Sabreena Safuan, et al.. (2021). Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks. RSC Medicinal Chemistry. 12(9). 1540–1554. 17 indexed citations
5.
Upadhyay, Neha, Kalpana Tilekar, Sabreena Safuan, et al.. (2021). Recent Anti‐angiogenic Drug Discovery Efforts To Combat Cancer. ChemistrySelect. 6(23). 5689–5700. 5 indexed citations
6.
Upadhyay, Neha, et al.. (2021). Mechanistic Insights into Binding of Ligands with Thiazolidinedione Warhead to Human Histone Deacetylase 4. Pharmaceuticals. 14(10). 1032–1032. 9 indexed citations
7.
Upadhyay, Neha, Kalpana Tilekar, Sabreena Safuan, et al.. (2021). Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis. Bioorganic Chemistry. 116. 105350–105350. 17 indexed citations
8.
9.
Tilekar, Kalpana, Neha Upadhyay, Denisse A. Gutiérrez, et al.. (2021). HDAC4 Inhibitors with Cyclic Linker and Non‐hydroxamate Zinc Binding Group: Design, Synthesis, HDAC Screening and in   vitro Cytotoxicity evaluation.. ChemistrySelect. 6(26). 6748–6763. 11 indexed citations
10.
Upadhyay, Neha, Kalpana Tilekar, Sabreena Safuan, et al.. (2021). Development and Investigation of Thiazolidinedione and Pyrazoline Compounds As Antiangiogenic Weapons Targeting VEGFR-2. Future Medicinal Chemistry. 13(22). 1963–1986. 5 indexed citations
11.
Upadhyay, Neha, et al.. (2021). Benefits and pitfalls: Epigenetic modulators in prostate cancer intervention. SHILAP Revista de lepidopterología. 1. 100006–100006. 8 indexed citations
12.
Tilekar, Kalpana, Neha Upadhyay, Piotr Mrówka, et al.. (2020). Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential. European Journal of Medicinal Chemistry. 202. 112603–112603. 28 indexed citations
13.
Tilekar, Kalpana, Neha Upadhyay, Piotr Mrówka, et al.. (2020). Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells. European Journal of Pharmaceutical Sciences. 154. 105512–105512. 29 indexed citations
14.
Tilekar, Kalpana, Neha Upadhyay, Cristina V. Iancu, et al.. (2020). Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(2). 188457–188457. 58 indexed citations
15.
Upadhyay, Neha, Kalpana Tilekar, Piotr Mrówka, et al.. (2020). Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation. Bioorganic Chemistry. 100. 103934–103934. 43 indexed citations
16.
Upadhyay, Neha, Kalpana Tilekar, Fulvio Loiodice, et al.. (2020). Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy. Bioorganic Chemistry. 107. 104527–104527. 34 indexed citations
17.
Patil, Vijay, et al.. (2020). Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib. Bioorganic & Medicinal Chemistry Letters. 30(23). 127561–127561. 14 indexed citations
18.
Tilekar, Kalpana, Neha Upadhyay, Franz‐Josef Meyer‐Almes, et al.. (2020). Synthesis and Biological Evaluation of Pyrazoline and Pyrrolidine‐2,5‐dione Hybrids as Potential Antitumor Agents. ChemMedChem. 15(19). 1813–1825. 30 indexed citations
19.
20.
Patil, Vijay, et al.. (2010). Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives. European Journal of Medicinal Chemistry. 45(10). 4539–4544. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hea-Young Park Choo Breakdown of academic impact, for papers by Olga E. Andreeva Breakdown of academic impact, for papers by V. Vigneshwaran Breakdown of academic impact, for papers by Anna I. Koutsourea Breakdown of academic impact, for papers by Hongchan An Breakdown of academic impact, for papers by Lan Shen Breakdown of academic impact, for papers by Yasmin M. Attia Breakdown of academic impact, for papers by Sudhakar Manda Breakdown of academic impact, for papers by Koji Ohsumi Breakdown of academic impact, for papers by Eman Y. Ahmed
Rankless by CCL
2026